| Literature DB >> 33331922 |
Elizabeth Price1, Alexander Allen2, Saaeha Rauz3, Anwar Tappuni4, Nurhan Sutcliffe5, Michele Bombardieri6, Sara Carty7, Coziana Ciurtin8, Bridget Crampton9, Lisa Duncalfe10, Benjamin Fisher11, Peter Glennon12, Katie L Hackett13, Genevieve Larkin14, Wan-Fai Ng15, Athimalaipet V Ramanan16, Saad Rassam17, Stephen B Walsh18, Simon Bowman19.
Abstract
The guideline will be developed using the methods and processes outlined in Creating Clinical Guidelines: Our Protocol [1]. This development process to produce guidance, advice and recommendations for practice has National Institute for Health and Care Excellence (NICE) accreditation.Entities:
Keywords: Keywords: Sjogren’s Guideline Sicca Management
Mesh:
Substances:
Year: 2021 PMID: 33331922 DOI: 10.1093/rheumatology/keaa870
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580